Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glimpure MV 2.3 Tablet

Prescription Icon
Prescription Required

Marketer

Arrient Healthcare Pvt Ltd

Salt Composition

Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.3mg)

Overview Glimpure MV 2.3 Tablet

Diabetace Control Tablets, a formulation containing anti-diabetic agents, manages type 2 diabetes in adults. This combination medication regulates blood glucose levels. Administer this medication with meals, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on blood sugar monitoring. Continuous use is crucial; discontinuation without medical consultation risks elevated blood sugar, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. This medication complements a comprehensive diabetes management plan including diet, exercise, and weight management as directed by your healthcare provider. Lifestyle choices significantly influence diabetes control. Hypoglycemia (low blood sugar) is a frequent side effect; learn to recognize symptoms like sweating, dizziness, headache, and tremors, and carry readily-available glucose sources. Alcohol consumption elevates hypoglycemia risk and should be limited. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headaches, swelling, blurred vision, bone fractures, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Individuals with a history of heart disease should inform their physician before commencing treatment. Pregnant or lactating individuals require medical consultation prior to use. Regular blood glucose monitoring, along with blood tests to assess blood cell counts and liver function, are recommended.

Uses of Glimpure MV 2.3 Tablet

Managing type 2 diabetes

Major Benefits of Glimpure MV 2.3 Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Glimpure MV 2.3 Tablet whole; avoid chewing, crushing, or breaking it. Administer on an empty stomach.

Common Side effects of Glimpure MV 2.3 Tablet:

  • Nausea
  • Diarrhea
  • Abdominal pain
  • Hypoglycemia (low blood glucose level)
  • Loss of appetite

How to use Glimpure MV 2.3 Tablet:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the Glimpure MV 2.3 Tablet whole; avoid chewing, crushing, or fracturing it. Administer on an empty stomach.

How Glimpure MV 2.3 Tablet works:

Each Glimpure MV 2.3 Tablet contains a triple-action formulation of antidiabetic agents.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Glimpure MV 2.3 Tablet and alcohol is not recommended due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Glimpure MV 2.3 Tablet during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the potential advantages against any risks prior to prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Glimpure MV 2.3 Tablet while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if such symptoms arise.

KidneyKidneyUNSAFE

Employing Glimpure MV 2.3 Tablets in individuals with kidney impairment poses a likely safety risk and is best avoided. Medical advice is recommended. Furthermore, its use is contraindicated in patients exhibiting severe kidney dysfunction.

LiverLiverCAUTION

Patients with liver impairment should use Glimpure MV 2.3 Tablets cautiously, potentially requiring dosage modification. Consultation with a physician is advised. For those with mild to moderate liver disease, initiation should be at a low dose; the medication is contraindicated in cases of severe hepatic dysfunction.

What if you forget to take Glimpure MV 2.3 Tablet :

Should you forget a Glimpure MV 2.3 Tablet dose, take it immediately if you remember. Otherwise, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Glimpure MV 2.3 Tablet

LabelValue
Potential for Dependence None.
Type of Medication Medication for diabetes

FAQs on Glimpure MV 2.3 Tablet

Glimpure MV 2.3 Tablet combines glimepiride, metformin, and voglibose to manage type 2 diabetes mellitus in adults. This medication helps regulate blood sugar when used with a healthy diet and exercise regimen. Glimepiride stimulates insulin secretion from the pancreas, reducing blood glucose. Metformin decreases hepatic glucose production and enhances insulin responsiveness. Voglibose, an alpha-glucosidase inhibitor, reduces post-meal glucose levels. This formulation is unsuitable for treating type 1 diabetes.
Patients taking Glimpure MV 2.3 Tablets may experience common adverse events including low blood sugar, nausea, diarrhea, altered taste perception, gas, abdominal pain, headache, skin reactions, and respiratory infections.
Patients with hypersensitivity to Glimpure MV 2.3 Tablet constituents or inactive ingredients should not take this medication. Its use is contraindicated in individuals with moderate to severe renal impairment, inflammatory bowel conditions, colonic ulcers, and metabolic acidosis, including diabetic ketoacidosis.
Combining Glimpure MV 2.3 Tablet and alcohol is unsafe. This combination can reduce blood sugar to dangerously low levels (hypoglycemia) and heighten the risk of lactic acidosis.
Indeed, Glimpure MV 2.3 Tablets may induce hypoglycemia, characterized by low blood glucose. Manifestations of low blood sugar can encompass nausea, headache, irritability, increased hunger, sweating, vertigo, tachycardia, and feelings of anxiety or tremor. The risk is heightened by skipped or delayed meals, alcohol consumption, excessive physical activity, or concomitant use of other antidiabetic medications. Consequently, consistent blood glucose monitoring is crucial. Maintaining readily available glucose sources, such as glucose tablets, honey, or fruit juice, is advisable.
Retain this medication within its original, sealed packaging. Follow the storage guidelines printed on the packaging or label. Discard any leftover medication. Ensure it remains inaccessible to children, pets, and others.
Glimpure MV 2.3 Tablet
172
MRP 210
18% off